(Q33976759)

30 July 2017

0 references

1 reference

title

Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis (English)

1 reference

30 July 2017

1 reference

Gupta AK

1

1 reference

30 July 2017

Ryder JE

series ordinal

2

1 reference

30 July 2017

Johnson AM

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

British Journal of Dermatology

30 July 2017

published in

1 reference

30 July 2017

volume

150

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

537-544

1 reference

Meta-analysis in clinical trials

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Terbinafine vs. placebo for onychomycosis in black patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Itraconazole in onychomycosis: intermittent dose schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Itraconazole in the treatment of onychomycosis: a double-blind comparison with miconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Efficacy of terbinafine for toenail onychomycosis. A multicenter trial of various treatment durations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Therapeutic efficacy and safety of one-week intermittent therapy with itraconazole for onychomycosis in a Chinese patient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Long-term results in patients with onychomycosis treated with terbinafine or itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Clinical trial: the safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Oral terbinafine treatment for toenail onychomycosis: follow-up after 5-6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Long-term outcomes in the treatment of toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Long-term evaluation of terbinafine 250 and 500 mg daily in a 16-week oral treatment for toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Appraising systematic reviews and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

The management of established postherpetic neuralgia: a comparison of the quality and content of traditional vs. systematic reviews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

The importance of quality of primary studies in producing unbiased systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Oral treatments for toenail onychomycosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Long-term efficacy of antifungals in toenail onychomycosis: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05728.X

10.1046/J.1365-2133.2003.05728.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference